Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

NCT00750659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER_GOV

Sponsor class

Conditions

Chronic Myeloid Leukemia
Acute Lymphoblastic Leukemia
Stem Cell Transplantation

Interventions

DRUG: Nilotinib

Sponsor

Sheba Medical Center